Advertisement
Advertisement
Trending on Urology Times
1
FDA approves cefepime and zidebactam for complicated UTI
2
Phase 1 AcTION trial establishes RP2D for 225Ac-PSMA-617
3
FDA updates in urology: May 2026
4
Pedro Barata, MD, highlights phase 3 data on 177Lu-rosopatamab tetraxetan in mCRPC
5